Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Ainara EstangaCenter for Research and Memory Clinic, CITA-Alzheimer Foundation, 20009 Donostia-San Sebastián, Spain.
Iñigo Tellaetxe-ElorriagaComputational Neuroimaging Laboratory, Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.ORCID 0009-0001-1832-5183
Mirian Ecay-TorresCenter for Research and Memory Clinic, CITA-Alzheimer Foundation, 20009 Donostia-San Sebastián, Spain.ORCID 0000-0001-7170-6180
Jorge García CondadoComputational Neuroimaging Laboratory, Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.
Maite García-SebastiánCenter for Research and Memory Clinic, CITA-Alzheimer Foundation, 20009 Donostia-San Sebastián, Spain.ORCID 0000-0003-3480-6056
Maria ArribaCenter for Research and Memory Clinic, CITA-Alzheimer Foundation, 20009 Donostia-San Sebastián, Spain.
Carolina LópezCenter for Research and Memory Clinic, CITA-Alzheimer Foundation, 20009 Donostia-San Sebastián, Spain.
Naia RosCenter for Research and Memory Clinic, CITA-Alzheimer Foundation, 20009 Donostia-San Sebastián, Spain.ORCID 0009-0007-6662-8676
Ane IriondoCenter for Research and Memory Clinic, CITA-Alzheimer Foundation, 20009 Donostia-San Sebastián, Spain.
Imanol Reparaz-EscuderoCenter for Research and Memory Clinic, CITA-Alzheimer Foundation, 20009 Donostia-San Sebastián, Spain.ORCID 0009-0001-5427-8214
Asier ErramuzpeComputational Neuroimaging Laboratory, Biobizkaia Health Research Institute, 48903 Barakaldo, Spain.ORCID 0000-0002-9402-2184
Pablo Martínez-LageCenter for Research and Memory Clinic, CITA-Alzheimer Foundation, 20009 Donostia-San Sebastián, Spain.ORCID 0000-0001-5404-9967
Miren AltunaCenter for Research and Memory Clinic, CITA-Alzheimer Foundation, 20009 Donostia-San Sebastián, Spain.ORCID 0000-0001-9709-5314
Funding
Instituto de Salud Carlos III (Co-funded by European Regional Development Fund; "A way to make Europe") PI21/00718Red guipuzcoana de Ciencia, Tecnología e Innovación - Gipuzkoa NEXT 2022 from the Gipuzkoa Provincial Council 2022-CIEN-000088-04-01
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
age modelingagingAlzheimer’s diseasebiomarkerscognitioncognitive age deltacognitive reservelifestyle factorsvascular pathologyvocabulary
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Cognitive Age Delta as a Marker of Healthy and Pathological Cognitive Aging: The Role of Lifestyle, Cognitive Reserve, and Vascular Risk. · full record | OpenQuestion